VivoSim Labs, Inc. Restructuring Reserve
VivoSim Labs, Inc. (VIVS) had Restructuring Reserve of $225.00 thousand as of 2019-12-31, per its 10-Q filed 2020-02-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2020-02-10
- 2019-12-31: Restructuring Reserve $225.00K.
- 2019-09-30: Restructuring Reserve $804.00K.
- 2019-03-31: Restructuring Reserve $0.00.
| Period end | Restructuring Reserve |
|---|---|
| 2019-12-31 | $225.00K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $804.00K 10-Q · filed 2019-11-07 |
| 2019-03-31 | $0.00 10-Q · filed 2020-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |